公司資料
BioVie Inc. 股價、新聞與催化劑
- 股票代碼:
- BIVI
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.95 USD (+4.84%)
收盤價
最後更新: 2026年8月21日
12.8M USD
市值
股價為何變動
As of Aug 21, 2026, BIVI closed up 4.84% at $1.95. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
BioVie is a biotechnology company focused on neurodegeneration, inflammation, and chronic disease biology. Its story has centered on trying to build a therapeutic platform in areas with large unmet need but high development risk.
所在地與產業分類
BioVie is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology.
商業模式特徵
The company depends on clinical progress, strategic focus, and financing discipline. Investors usually watch early data, pipeline direction, and whether the company can preserve enough runway.
生技產業定位
BioVie occupies a speculative small-cap biotech niche. It is a catalyst-sensitive story where the market is still waiting for a clear clinical breakthrough.
未來催化劑
- BioVie’s catalysts are azeliragon-related programs and any strategic or clinical update that clarifies the company’s path. The next step matters because the company still needs a strong human-data signal.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。